The world is different today than how it was 17 years ago. Seventeen years ago, there were only 5.8 billion people in the world (The World Bank). Today, the world’s population has grown to more than 7 billion (Population Reference Bureau), and is estimated to be at a staggering 8 billion by 2030, or 17 years from now. Today, the world has more to feed, clothe, and shelter. Doing this on limited and decreasing resources and inputs is an insurmountable task – a challenge that has been met with a variety of options, including biotech crop technology.
The recently released 2012 Global Status of Commercialized Biotech/GM Crops, authored by Clive James, ISAAA Board Chair, reports that an unprecedented 100-fold increase in global biotech crop plantings was recorded last year, from 1.7 million hectares in 1996 to 170.3 million hectares in 2012, making biotech crops the fastest adopted crop technology in recent history.
Seventeen years after the first biotech crop was commercialized, or almost two decades ago, developing countries, for the first time, have grown more biotech crops than industrial countries, producing 52 percent of the total global production in 2012. Of the 28 countries that planted biotech crops last year, 20 were developing, while only 8 industrial countries planted biotech crops, compared with 19 developing and 10 industrial countries in 2011.
From 1996 to 2012, millions of farmers in almost 30 countries worldwide made the decision to plant and replant biotech crops at an accumulated hectarage of more than 1.5 billion hectares. In 2012 alone, 17.3 million farmers grew biotech crops, up by 0.6 million from 2011, of which more than 90% or over 15 million are small, resource-poor farmers in developing countries.
Two new countries, both developing, planted biotech crops for the first time last year. Sudan planted Bt cotton, while Cuba grew Bt maize. Sudan is the fourth country in Africa to plant a biotech crop after South Africa, Burkina Faso, and Egypt. About 10,000 farmers were the initial beneficiaries of the technology who have an average of 1-2.5 hectares of land. In a similar development in Latin America, Cuba became the 11th Latin American country to plant biotech crops. For the first time, Cuban farmers grew 3,000 hectares of hybrid Bt maize commercially.
Despite the enormous leap in biotech crop production of developing countries, the USA remained and continued its leadership in producing biotech crops in 2012 with 69.5 million hectares, an average adoption rate of ~90% across all biotech crops. Since 2006, the USA has planted eight biotech crops, namely: maize, soybean, cotton, canola, sugarbeet, alfalfa, papaya, and squash.
Second to the USA, but emerging as a global leader in biotech crop production is Brazil, which produced 36.6 million hectares of biotech crops in 2012, a total of 6.3 million hectares more than its hectarage in 2011. For the fourth consecutive year, Brazil increased biotech crop plantings more than any other country in the world.
According to Clive James, the growth seen in global production of biotech crops is “contrary to the prediction of critics, who prior to the commercialization of the technology in 1996 prematurely declared that biotech crops were only for industrial countries, and would never be accepted and adopted by developing countries.” He added that risk-averse farmers put their trust and confidence in biotechnology because biotech crops deliver substantial, sustainable, socio-economic and environmental benefits.
|Farmers in India planted a record 10.8 million hectares of Bt cotton in 2012 with an adoption rate of 93%.|
The near-term looks encouraging with new improved crops such as the first biotech drought tolerant maize approved for planting in the USA in 2013 and also the first planting of the stacked soybean in Brazil and neighboring countries in South America in 2013. Vitamin A enhanced Golden rice could be released in the Philippines by 2013/2014, subject to regulatory approval. Going forward, global growth of biotech crop hectares is likely to be more modest due to the already high rate of adoption in all the principal crops in mature markets in both developing and industrial countries, the author said.
For more information about ISAAA, the Global Status of Commercialized Biotech/GM Crops Briefs, and other information resources, visit the ISAAA website at http://www.isaaa.org/.